BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2895 related articles for article (PubMed ID: 14762345)

  • 21. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization.
    Bax JJ; Maddahi J; Poldermans D; Elhendy A; Cornel JH; Boersma E; Roelandt JR; Fioretti PM
    J Nucl Med; 2002 Jun; 43(6):795-802. PubMed ID: 12050325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular reconstruction benefits patients with ischemic cardiomyopathy and non-viable myocardium.
    Ribeiro GA; da Costa CE; Lopes MM; Albuquerque AN; Antoniali F; Reinert GA; Franchini KG
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):196-201. PubMed ID: 16388958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of myocardial revascularisation on left ventricular systolic function in patients with and without viable myocardium: should non-viable segments be revascularised?
    Stipac AV; Stankovic I; Vidakovic R; Putnikovic B; Ilic I; Milicic B; Neskovic AN
    Heart; 2013 Dec; 99(23):1749-54. PubMed ID: 23906733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization.
    Penicka M; Tousek P; De Bruyne B; Wijns W; Lang O; Madaric J; Vanderheyden M; Tintera J; Malý M; Widimsky P; Bartunek J
    Eur Heart J; 2007 Jun; 28(11):1366-73. PubMed ID: 17208936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium.
    Acampa W; Petretta M; Spinelli L; Salvatore M; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):430-7. PubMed ID: 15821962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting.
    Depré C; Vanoverschelde JL; Gerber B; Borgers M; Melin JA; Dion R
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):371-8. PubMed ID: 9040632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.
    Meluzín J; Cerný J; Frélich M; Stetka F; Spinarová L; Popelová J; Stípal R
    J Am Coll Cardiol; 1998 Oct; 32(4):912-20. PubMed ID: 9768711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction.
    Vanoverschelde JL; D'Hondt AM; Marwick T; Gerber BL; De Kock M; Dion R; Wijns W; Melin JA
    J Am Coll Cardiol; 1996 Aug; 28(2):432-42. PubMed ID: 8800122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do the presence and amount of dysfunctional but viable myocardium affect the perioperative outcome of coronary artery bypass graft surgery?
    Meluzín J; Cerný J; Nemec P; Frélich M; Stetka F; Spinarová L
    Int J Cardiol; 1999 Dec; 71(3):265-72. PubMed ID: 10636534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse redistribution on exercise-redistribution (201)Tl SPECT in chronic ischemic dysfunction: predictive of functional outcome after revascularization?
    Roelants VA; Vanoverschelde JL; Vander Borght TM; Melin JA
    J Nucl Med; 2002 May; 43(5):621-7. PubMed ID: 11994524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent dysfunction of viable myocardium after revascularization in chronic ischaemic heart disease: implications for dobutamine stress echocardiography with longitudinal systolic strain and strain rate measurements.
    Rösner A; Avenarius D; Malm S; Iqbal A; Baltabaeva A; Sutherland GR; Bijnens B; Myrmel T
    Eur Heart J Cardiovasc Imaging; 2012 Sep; 13(9):745-55. PubMed ID: 22379128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of revascularisation and contractile reserve on left ventricular remodelling in patients with impaired left ventricular function.
    Khoury VK; Haluska B; Fathi R; Marwick TH
    Int J Cardiol; 2004 Jan; 93(1):55-61. PubMed ID: 14729436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography and low-dose dobutamine echocardiography in the prediction of postrevascularization improvement in left ventricular function and exercise parameters.
    Wiggers H; Nielsen TT; Bøttcher M; Egeblad H; Bøtker HE
    Am Heart J; 2000 Dec; 140(6):928-36. PubMed ID: 11099997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease.
    deFilippi CR; Willett DL; Irani WN; Eichhorn EJ; Velasco CE; Grayburn PA
    Circulation; 1995 Nov; 92(10):2863-8. PubMed ID: 7586253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Milrinone echocardiographic viability test: a pilot study.
    Dhar SC; Birnbaum Y; Hayes S; Naqvi T; Cercek B; Blanche C; Friedman A; Trento A; Siegel RJ
    J Am Soc Echocardiogr; 2001 Jul; 14(7):668-75. PubMed ID: 11447411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.
    Maruskova M; Gregor P; Bartunek J; Tintera J; Penicka M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):62-8. PubMed ID: 19577058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated analysis of cardiac tissue structure and function for improved identification of reversible myocardial dysfunction.
    Hoffmann R; Stempel K; Kühl H; Balzer J; Krämer N; Krombach G; Kelm M; Becker M
    Coron Artery Dis; 2009 Jan; 20(1):21-6. PubMed ID: 19008764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons.
    Ogawa M; Doi K; Fukumoto A; Yaku H
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):673-5. PubMed ID: 17670732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of dobutamine radionuclide ventriculography for prediction of left ventricular function improvement after coronary artery bypass grafting for ischemic cardiomyopathy.
    Zafrir N; Vidne B; Sulkes J; Sclarovsky S
    Am J Cardiol; 1999 Mar; 83(5):691-5. PubMed ID: 10080420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 145.